S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
Log in
CVE:PAS

Pascal Biosciences Inc. (PAS.V) Stock Forecast, Price & News

C$0.10
-0.01 (-4.55 %)
(As of 01/19/2021 02:43 PM ET)
Add
Compare
Today's Range
C$0.11
Now: C$0.11
C$0.12
50-Day Range
C$0.00
MA: C$0.14
C$0.16
52-Week Range
C$0.07
Now: C$0.11
C$0.45
Volume25,850 shs
Average Volume95,961 shs
Market CapitalizationC$6.05 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pascal Biosciences Inc., a biopharmaceutical company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory molecule to enhance the efficacy of checkpoint inhibitors. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.

MarketRank

Overall MarketRank

0.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-6886775
Employees5

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.00 per share
Book ValueC($0.01) per share

Profitability

Miscellaneous

Market CapC$6.05 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.10
-0.01 (-4.55 %)
(As of 01/19/2021 02:43 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PAS News and Ratings via Email

Sign-up to receive the latest news and ratings for PAS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pascal Biosciences Inc. (PAS.V) (CVE:PAS) Frequently Asked Questions

How has Pascal Biosciences Inc. (PAS.V)'s stock been impacted by Coronavirus (COVID-19)?

Pascal Biosciences Inc. (PAS.V)'s stock was trading at C$0.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PAS shares have increased by 5.0% and is now trading at C$0.11.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Pascal Biosciences Inc. (PAS.V)?

Wall Street analysts have given Pascal Biosciences Inc. (PAS.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pascal Biosciences Inc. (PAS.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Pascal Biosciences Inc. (PAS.V)'s key competitors?

What other stocks do shareholders of Pascal Biosciences Inc. (PAS.V) own?

Who are Pascal Biosciences Inc. (PAS.V)'s key executives?

Pascal Biosciences Inc. (PAS.V)'s management team includes the following people:
  • Dr. Patrick W. Gray, CEO & Director (Age 69, Pay $256.57k)
  • Ms. Judith F. Dalling L.L.B., CFO & Corp. Sec. (Age 66, Pay $65k)

What is Pascal Biosciences Inc. (PAS.V)'s stock symbol?

Pascal Biosciences Inc. (PAS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS."

How do I buy shares of Pascal Biosciences Inc. (PAS.V)?

Shares of PAS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Pascal Biosciences Inc. (PAS.V)'s stock price today?

One share of PAS stock can currently be purchased for approximately C$0.11.

How big of a company is Pascal Biosciences Inc. (PAS.V)?

Pascal Biosciences Inc. (PAS.V) has a market capitalization of C$6.05 million. Pascal Biosciences Inc. (PAS.V) employs 5 workers across the globe.

What is Pascal Biosciences Inc. (PAS.V)'s official website?

The official website for Pascal Biosciences Inc. (PAS.V) is www.biommune.net.

How can I contact Pascal Biosciences Inc. (PAS.V)?

Pascal Biosciences Inc. (PAS.V)'s mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The company can be reached via phone at +1-604-6886775.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.